Companies: 10,795·Total market cap: $144.5T

Biofrontera Inc.

Biofrontera Inc.

BFRINASDAQHealthcare● Active

$0.94

+$0.01(+0.53%)

Market Cap$12035143

P/E Ratio—

52W High$1.19

52W Low$0.555

Avg Volume175K

Open$0.95

Beta0.85

股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

Biofrontera Inc.（BFRI）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BFRI · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-1.12Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$43.2MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding10.2MShares outstanding history

Next EarningsAug 12, 2026Est.Earnings history

探索 Biofrontera Inc. 数据

分析师预测$— · Buy

股息不分红

营收$41.7M+11.80%

盈利EPS $-1.04+67.70%

财务快照

FY 2025Revenue$41.7M▲ +11.80% YoY

202320242025

FY 2025Net Income-$10.5M▲ +40.67% YoY

202320242025

FY 2025EPS$-1.04▲ +67.70% YoY

202320242025

TTM:Revenue: $43.2MNet Income: -$11.1MEPS: $-1.12View income statement →

分析师评级与目标价

Buy1 位分析师

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$0.94Current

$—Avg Target

$—High

合计: 1 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Biofrontera Inc.

$0.94+0.53%$12.0M #2

Aytu BioPharma, Inc.

$2.29+1.78%$18.5M #3

Cocrystal Pharma, Inc.

$1.01+4.74%$10.3M #4

Dogwood Therapeutics, Inc.

$1.49-1.00%$2.8M #5

$0.61-1.21%$5.3M #6

Gelteq Limited Ordinary Shares

$0.48-3.40%$4.4M

股票表现

1D+0.70%

1W-9.47%

1M-18.13%

3M+9.60%

YTD+65.18%

1Y+56.92%

5Y-98.93%

关于 Biofrontera Inc.

CEOHermann Luebbert

IPO DateOct 29, 2021

Employees92

CountryUS

Websitebiofrontera.us.com

Biofrontera Inc. a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Amelu…

Drug Manufacturers - Specialty & Generic HealthcareNASDAQUS

关于股票概览与关键数据

Biofrontera Inc.（BFRI）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Oct 29, 2021 在 NASDAQ 上市。截至最近交易日，BFRI 股价为 $0.94，市值约为 $12.1M。过去12个月累计回报 +56.92%，年初至今回报 +65.18%。

根据 1 位华尔街分析师，Biofrontera Inc. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 Biofrontera Inc. 营收 $41.7M，净利润 -$10.5M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Biofrontera Inc.（BFRI）股价为 $0.94，在 NASDAQ 上市，52周区间为 $0.56 – $1.19。

BFRI 最新股价BFRI quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议